St. Jude Medical, Inc.
CORRECTING and REPLACING St. Jude Medical Announces FDA Approval of Current Plus ICD and Promote Plus CRT-D Devices to Provide Therapy for Life-Threatening Arrhythmias and Heart Failure
Published in Drug Week, May 29th, 2009
The corrected release reads: ST. JUDE MEDICAL ANNOUNCES FDA APPROVAL OF CURRENT PLUS ICD AND PROMOTE PLUS CRT-D DEVICES TO PROVIDE THERAPY FOR LIFE-THREATENING ARRHYTHMIAS AND HEART FAILURE St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) approval of the Promote® Plus cardiac resynchronization therapy defibrillator (CRT-D) and Current® Plus implantable cardioverter defibrillators (ICDs), designed with TailoredTherapy™ features that give physicians more options for customizing therapy for patients with potentially...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2009-05-29)
More Articles from Drug Week
- American Associates, Ben-Gurion University of the Negev
Ben-Gurion U of the Negev study demonstrates link between appetite and elderly mortality - American Cancer Society
Review finds conflicts of interest in many cancer studies - American Dietetic Association
ADA releases position paper on obesity, reproduction and pregnancy outcomes - BioMed Central
Improving education may cut smoking in youth - BioMed Central
Sodium bicarbonate reduces incidence of contrast-induced nephropathy - Group Health Cooperative Center for Health Studies
Acupuncture eases chronic low back pain in SPINE trial - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
